Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Martin Brejcha
Observed names:
Brejcha, Martin,
M Brejcha,
M. Brejcha
OpenAlex ID:
A5050677270
Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage
2009
·
Jitka Malcikova
, Jana Smardova
, et al.
·
Blood
·
184
PDF
Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data
2013
·
Panagiotis Baliakas
, Michalis Iskas
, et al.
·
American Journal of Hematology
·
129
PDF
Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice
2011
·
Michael Doubek
, Jiří Mayer
, et al.
·
European Journal Of Haematology
·
18
Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: A prospective analysis
2013
·
Martin Brejcha
, Martina Stoklasová
, et al.
·
Leukemia Research
·
16
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real‐world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)
2023
·
Martin Špaček
, Lukáš Smolej
, et al.
·
British Journal of Haematology
·
13
PDF
Prediction of Progression of Smouldering into Therapy Requiring Multiple Myeloma By Easily Accessible Clinical Factors [in 527 Patients]
2014
·
Roman Hajek
, Viera Sandecka
, et al.
·
Blood
·
13
Real‐world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO‐CLLEAR Study by the Czech CLL Study Group
2020
·
Anna Panovská
, Lucie Němcová
, et al.
·
Hematological Oncology
·
11
Low‐dose fludarabine and cyclophosphamide combined with rituximab in the first‐line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long‐term results of project Q‐lite by the Czech CLL Study Group
2021
·
Lukáš Smolej
, Yvona Brychtová
, et al.
·
British Journal of Haematology
·
10
PDF
External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score
2020
·
Lukáš Smolej
, Peter Turcsányi
, et al.
·
British Journal of Haematology
·
10
PDF
Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myeloma.
2011
·
P Kessler
, L Pour
, et al.
·
PubMed
·
8
[Staging of non-Hodgkin's lymphoma--recommendations of the Czech Lymphoma Study Group].
2010
·
A Sýkorová
, D Belada
, et al.
·
PubMed
·
8
Recommendations for chronic lymphocytic leukaemia dia gnosis and therapy 2021
2021
·
Lukáš Smolej
, Martin Špaček
, et al.
·
Transfuze a hematologie dnes
·
4
[Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
2012
·
Z Adam
, Z Rehák
, et al.
·
PubMed
·
4
Median Absolute Lymphocyte Count Independently Predicts Survival of Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-Chemotherapy: Analysis of 651 Patients Included In the Czech Lymphoma Project
2010
·
Vit Prochazka
, Marek Trneny
, et al.
·
Blood
·
4
Clinical and laboratory features of leukemias at the time of diagnosis: An analysis of 1,004 consecutive patients
2011
·
Zdenek Racil
, Lucie Buresova
, et al.
·
American Journal of Hematology
·
2
[Alemtuzumab in chronic lymphocytic leukemia treatment: retrospective analysis of outcome according to cytogenetics].
2009
·
M Doubek
, A Jungová
, et al.
·
PubMed
·
2
[Preparation of patients on anticoagulant treatment for invasive surgery].
2009
·
M Brejcha
, J Gumulec
, et al.
·
PubMed
·
2
[Hemorrhagic complications during warfarin treatment].
2006
·
J Gumulec
, P Kessler
, et al.
·
PubMed
·
2
Comparable outcomes of BTK inhibitors and fixed-duration venetoclax plus rituximab in second-line treatment of chronic lymphocytic leukaemia: a real-world analysis by the Czech CLL study group
2026
·
Jana Mihályová
, Anna Panovská
, et al.
·
Annals of Hematology
·
1
Recommendations for chronic lymphocytic leukaemia diagnosis and therapy
2025
·
Martin Špaček
, Martin Šimkovič
, et al.
·
Transfuze a hematologie dnes
·
1
Beyond rituximab maintenance. relapsing follicular lymphoma during or after end of rituximab maintenance: analysis of C zech L ymphoma S tudy G roup ( CLSG ) database
2017
·
A. Janikova
, V. Campr
, et al.
·
Hematological Oncology
·
1
PDF
Evaluation of Current Clinical Models for Risk of Progression from Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma or Related Malignancies in 2028 Persons Followed in the Czech Republic
2014
·
Viera Sandecka
, Zdenek Adam
, et al.
·
Blood
·
1
New prognostic markers of chronic lymphocytic leukemia in theeveryday hematological practice. A multicenter analysis.
2009
·
Michael Doubek
, Eduard Cmunt
, et al.
·
Haematologica
·
1
[Prevention of venous thromboembolism: generally accepted guidelines].
2006
·
J Gumulec
, M Penka
, et al.
·
PubMed
·
1
Bleeding complications of anticoagulant therapy
1989
·
J Gumulec
, P Kessler
, et al.
·
Reactions Weekly
·
1
Show more works
View as search
Works count:
62
Citation count:
447
H-index:
9
I10-index:
9
Year
Topic
Type
